摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-nitro-4-styrylaniline | 907951-31-9

中文名称
——
中文别名
——
英文名称
2-nitro-4-styrylaniline
英文别名
2-nitro-4-[(E)-2-phenylethenyl]aniline
2-nitro-4-styrylaniline化学式
CAS
907951-31-9
化学式
C14H12N2O2
mdl
——
分子量
240.261
InChiKey
QYDSEDUGTOHSPQ-VOTSOKGWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    71.8
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-nitro-4-styrylaniline 在 palladium diacetate 亚硝酸特丁酯2,6-二叔丁基-4-甲基苯酚三氟化硼乙醚N,N-二异丙基乙胺 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 0.75h, 生成 2-nitro-4-styryl-1-(4-vinyl-phenylsulfanyl)-benzene
    参考文献:
    名称:
    Synthesis and testing of new end-functionalized oligomers for molecular electronics
    摘要:
    Several new classes of oligomers have been synthesized with functionalities designed to aid in the understanding of molecular device behavior, specifically when molecules are interfaced between proximal electronic probes. The compounds synthesized are series of azobenzenes, bipyridines and oligo(phenylene vinylene)s that bear acetyl-protected thiols for ultimate attachment to metallic surfaces. Some initial electrochemical and solid-state test results are also reported. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2003.09.004
  • 作为产物:
    描述:
    苯乙烯4-碘-2-硝基苯胺 在 palladium diacetate N,N-二异丙基乙胺 作用下, 以 乙腈 为溶剂, 以69%的产率得到2-nitro-4-styrylaniline
    参考文献:
    名称:
    Synthesis and testing of new end-functionalized oligomers for molecular electronics
    摘要:
    Several new classes of oligomers have been synthesized with functionalities designed to aid in the understanding of molecular device behavior, specifically when molecules are interfaced between proximal electronic probes. The compounds synthesized are series of azobenzenes, bipyridines and oligo(phenylene vinylene)s that bear acetyl-protected thiols for ultimate attachment to metallic surfaces. Some initial electrochemical and solid-state test results are also reported. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2003.09.004
点击查看最新优质反应信息

文献信息

  • Inhibition and Dispersion of Bacterial Biofilms with 2-Aminobenzimidazole Derivatives
    申请人:BLACKWELL Helen
    公开号:US20130136782A1
    公开(公告)日:2013-05-30
    Compounds described herein inhibit biofilm formation or disperse pre-formed biofilms of Gram-negative bacteria. Biofilm-inhibitory compounds can be encapsulated or contained in a polymer matrix for controlled release. Coatings, films, multilayer films, hydrogels, microspheres and nanospheres as well as pharmaceutical compositions and disinfecting compositions containing biofilm-inhibitory compounds are also provided. Methods for inhibiting formation of biofilms or dispersing already formed biofilms are provided. Methods for treating infections of gram-negative bacteria which form biofilms, particularly those of Pseudomonas and more particularly P. aeruginosa.
    本文描述的化合物可以抑制革兰氏阴性细菌的生物膜形成或分散已形成的生物膜。生物膜抑制化合物可以被封装或包含在聚合物基质中以进行控制释放。此外,还提供了包含生物膜抑制化合物的涂层、薄膜、多层薄膜、凝胶、微球和纳米球,以及含有生物膜抑制化合物的制药组合物和消毒组合物。提供了抑制生物膜形成或分散已形成生物膜的方法。还提供了治疗革兰氏阴性细菌感染的方法,特别是那些形成生物膜的假单胞菌,尤其是P. aeruginosa。
  • AGENT FOR CONTROLLING FUNCTION OF GPR34 RECEPTOR
    申请人:Takeda Pharmaceutical Company Limited
    公开号:EP1849465A1
    公开(公告)日:2007-10-31
    The present invention provides a GPR receptor function regulator comprising the compound represented by the formula: [wherein ring A is an optionally substituted isocyclic or heterocyclic ring, P is a bond or spacer, ring D is an optionally substituted monocyclic aromatic ring which may be condensed with a 5-to 7-membered ring, V is a bond or the group represented by the formula -CR14=CR15 - or - N=CR16- (wherein R14, R15 and R16 each represents a hydrogen atom or optionally substituted hydrocarbon group), Q is a bond or spacer, and W is a carboxyl or a group biologically equivalent to a carboxyl] or its salt or a prodrug thereof
    本发明提供了一种 GPR 受体功能调节剂,包括由式表示的化合物: [其中环A是任选取代的异环或杂环,P是键或间隔物,环D是任选取代的单环芳香环,可与5-7元环缩合,V是键或由式-CR14=CR15-或-N=CR16-代表的基团(其中R14、R15 和 R16 各代表一个氢原子或任选取代的烃基),Q 是键或间隔物,W 是羧基或生物等价于羧基的基团]或其盐或其原药
  • Inhibition and dispersion of bacterial biofilms with 2-aminobenzimidazole derivatives
    申请人:WISCONSIN ALUMNI RESEARCH FOUNDATION
    公开号:US10292390B2
    公开(公告)日:2019-05-21
    Compounds described herein inhibit biofilm formation or disperse pre-formed biofilms of Gram-negative bacteria. Biofilm-inhibitory compounds can be encapsulated or contained in a polymer matrix for controlled release. Coatings, films, multilayer films, hydrogels, microspheres and nanospheres as well as pharmaceutical compositions and disinfecting compositions containing biofilm-inhibitory compounds are also provided. Methods for inhibiting formation of biofilms or dispersing already formed biofilms are provided. Methods for treating infections of gram-negative bacteria which form biofilms, particularly those of Pseudomonas and more particularly P. aeruginosa.
    本文所述化合物可抑制革兰氏阴性细菌生物膜的形成或驱散已形成的生物膜。生物膜抑制化合物可封装或包含在聚合物基质中,以实现控制释放。此外,还提供了含有生物膜抑制化合物的涂层、薄膜、多层膜、凝胶、微球和纳米球以及药物组合物和消毒组合物。还提供了抑制生物膜形成或驱散已形成的生物膜的方法。提供了治疗形成生物膜的革兰氏阴性细菌感染的方法,特别是假单胞菌感染,尤其是绿假单胞菌感染。
  • Regulating Agent of GPR34 Receptor Function
    申请人:Itoh Fumio
    公开号:US20100130737A1
    公开(公告)日:2010-05-27
    The present invention provides a GPR receptor function regulator comprising the compound represented by the formula: [wherein ring A is an optionally substituted isocyclic or heterocyclic ring, P is a bond or spacer, ring D is an optionally substituted monocyclic aromatic ring which may be condensed with a 5- to 7-membered ring, V is a bond or the group represented by the formula —CR 14 ═CR 15 — or —N═CR 16 — (wherein R 14 , R 15 and R 16 each represents a hydrogen atom or optionally substituted hydrocarbon group), Q is a bond or spacer, and W is a carboxyl or a group biologically equivalent to a carboxyl] or its salt or a prodrug thereof.
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S,5R,5''R)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (4R,5S)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 黄子囊素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-白藜芦醇3-O-beta-D-葡糖苷酸 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1-(3-甲基-2-萘基)-2-(2-萘基)乙烯 顺式-1,2-双(三甲基硅氧基)-1,2-双(4-溴苯基)环丙烷 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 非洲李(PRUNUSAFRICANA)树皮提取物 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀杂质7 阿托伐他汀杂质5 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 锌(II)(苯甲醛)(四苯基卟啉) 银松素 铜酸盐(5-),[m-[2-[2-[1-[4-[2-[4-[[4-[[4-[2-[4-[4-[2-[2-(羧基-kO)苯基]二氮烯基-kN1]-4,5-二氢-3-甲基-5-(羰基-kO)-1H-吡唑-1-基]-2-硫代苯基]乙烯基]-3-硫代苯基]氨基]-6-(苯基氨基)-1,3,5-三嗪-2-基]氨基]-2-硫代苯基]乙烯基]-3-硫代 铒(III) 离子载体 I 铀,二(二苯基甲酮)四碘- 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯